Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DyStar is a global leader in specialty chemicals, providing a diverse portfolio of colorants, performance chemicals, and sustainable solutions to industries including textiles, leather, and life sciences. The company's Life Science division focuses on high-purity ingredients for the food and beverage, personal care, and pharmaceutical sectors, offering a range of preservatives, antioxidants, and chemical intermediates. Originally founded in 1995 as a joint venture between Bayer, Hoechst, and BASF, DyStar has expanded its capabilities through strategic acquisitions, such as the specialties business of Emerald Performance Materials. Today, the company operates as a subsidiary of the Zhejiang Longsheng Group (Lonsen) and is committed to driving environmental sustainability in the chemical industry. DyStar provides critical chemical building blocks and additives that support the manufacturing of healthcare and consumer products worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DyStar.